Results 101 to 110 of about 9,543,544 (289)
Antithyroid Drug Therapy for Graves' Disease and Implications for Recurrence
International Journal of Endocrinology, 2017 Graves' disease (GD) is the most common cause of hyperthyroidism worldwide. Current therapeutic options for GD include antithyroid drugs (ATD), radioactive iodine, and thyroidectomy. ATD treatment is generally well accepted by patients and clinicians due
Jia Liu, Jing Fu, Yuan Xu, Guang Wang
semanticscholar +1 more source
2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease.
Endocrinology and metabolism clinics of North America (Print), 2022 T. Hoang, D. Stocker, E. Chou, H. Burch
semanticscholar +1 more source
A case report of immune thrombocytopenic purpura as a rare Harbinger of Graves’ disease
Journal of Clinical and Translational Endocrinology Case Reports, 2022 Graves’ disease is one of the most common forms of autoimmune hyperthyroidism and has been linked with multiple or family histories of autoimmune diseases. In most cases, Graves' disease diagnosis is easily made by recognizing goiter, ophthalmopathy, and
Handoko Hariyono, Jongky Hendro Prajitno
doaj
Google Trends Analysis of COVID-19 [PDF]
arXiv, 2020 The World Health Organization (WHO) announced that COVID-19 was a pandemic disease on the 11th of March as there were 118K cases in several countries and territories. Numerous researchers worked on forecasting the number of confirmed cases since anticipating the growth of the cases helps governments adopting knotty decisions to ease the lockdowns ...
arxiv
Guidelines for the treatment of childhood-onset Graves’ disease in Japan, 2016
Clinical Pediatric Endocrinology, 2017 . Purpose behind developing these guidelines: Over one decade ago, the “Guidelines for the Treatment of Graves’ Disease with Antithyroid Drug, 2006” (Japan Thyroid Association (JTA)) were published as the standard drug therapy protocol for Graves ...
K. Minamitani +4 more
semanticscholar +1 more source
Transient neonatal hyperthyroidism [PDF]
, 2014 Graves’ disease is the main cause of hyperthyroidism in women of childbearing age. It occurs by the presence of serum immunoglobulins which stimulate the thyrotropin receptor (TRAbs) and may cross the placenta.
Dias, A +8 more
core
The Effect of Thionamide to TRH, TSH, IL-4, T-REG, and Anti-TPO in Graves’ Disease [PDF]
, 2019 The most common cause of hyperthyroidism is Graves' disease. TRH and TSH are hormonal factors that modulate and control thyroid function in Graves' disease.
Aprilia, Dinda +2 more
core +2 more sources
The Minimal Euclidean Function on the Gaussian Integers [PDF]
arXiv, 2018 The Minimal Euclidean Function on the Gaussian ...
arxiv
Graves’ disease following hypothyroidism due to Hashimoto’s thyroiditis in a black South African lady: a case report [PDF]
, 2019 Graves' disease and Hashimoto's thyroiditis are autoimmune thyroid disorders with distinct pathological and histopathological features. The conversion from Hashimoto's thyroiditis to Graves' disease has been rarely reported throughout the world with no ...
Chukwuma Ekpebegh +2 more
core +2 more sources
A Patient-Specific Treatment Model for Graves’ Hyperthyroidism [PDF]
, 2018 Background: Graves’ is disease an autoimmune disorder of the thyroid gland caused by circulating anti-thyroid receptor antibodies (TRAb) in the serum. TRAb mimics the action of thyroid stimulating hormone (TSH) and stimulates the thyroid hormone receptor
Antonelli, Alessandro +4 more
core +4 more sources